论文部分内容阅读
本月全球药品研发进展取得成效的药物有56个,较上月减少8个。除进入Ⅲ期的药品数量略有增加外,其他阶段药品数目均有一定下降。进入注册阶段的有29个,比上月减少8个。
There were 56 drugs that made progress in global drug development this month, down 8 from the previous month. Except for a slight increase in the number of drugs entering phase Ⅲ, the number of drugs in other phases decreased to a certain extent. There were 29 registrations, a decrease of 8 from the previous month.